EUVIMEDEUVIMED entdecken
Crossref

Quality by design (QbD) approach to formulate in situ gelling system for nose to brain delivery of Fluoxetine hydrochloride: Ex-vivo and In-vivo study

Inayat Bashir Pathan, Harshal Mene, Shripad Bairagi

Ars Pharmaceutica (Internet) · 20.09.2017 · 58 (3) · 107-114

DOI: 10.30827/ars.v58i3.6528 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Ars Pharmaceutica (Internet), online erschienen am 20.09.2017. Verfasst von Inayat Bashir Pathan und 2 weiteren Autor:innen. Die Arbeit wurde bisher 23-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

The purpose of the present study is to develop an ion sensitive in situ nasal gel of Fluoxetine hydrochloride for brain delivery. A 32 factorial design was used to investigate effect of independent variable on dependent variables.

Methods

Formulations were evaluated for gelation study, viscosity, gel strength, mucoadhesion strength, drug content, ex-vivo drug permeation, in vivo pharmacodynamic and stability study.

Results

The results revealed that as the concentration of gellan gum and HPMC were increased, there was increase in viscosity and mucoadhesive strength and decrease in percent release. The optimized formulation F4 showed highest drug release 94.24 %. In locomotor activity and forced swim test study, the in situ gel treated rats showed significant responses as compared to control group. Histopathological examinations showed no evidence of nasal mucosal damage. The in situ nasal gel was stable after 3 months.

Conclusion

It was concluded that, the in situ nasal formulations of Fluoxetine hydrochloride which enhanced nasal absorption and patient compliance for the treatment of depression.

Zitieren

APA

Pathan, I. B., Mene, H., & Bairagi, S. (2017). Quality by design (QbD) approach to formulate in situ gelling system for nose to brain delivery of Fluoxetine hydrochloride: Ex-vivo and In-vivo study. Ars Pharmaceutica (Internet), 58(3), 107-114. https://doi.org/10.30827/ars.v58i3.6528

Vancouver

Pathan IB, Mene H, Bairagi S. Quality by design (QbD) approach to formulate in situ gelling system for nose to brain delivery of Fluoxetine hydrochloride: Ex-vivo and In-vivo study. Ars Pharmaceutica (Internet). 2017;58(3):107-114. doi:10.30827/ars.v58i3.6528

BibTeX
@article{Pathan2017,
  author = {Pathan, Inayat Bashir and Mene, Harshal and Bairagi, Shripad},
  title = {Quality by design (QbD) approach to formulate in situ gelling system for nose to brain delivery of Fluoxetine hydrochloride: Ex-vivo and In-vivo study},
  journal = {Ars Pharmaceutica (Internet)},
  year = {2017},
  volume = {58},
  number = {3},
  pages = {107--114},
  doi = {10.30827/ars.v58i3.6528}
}
Kostenlos starten →